Literature DB >> 23154728

ANCA-associated vasculitis with central retinal artery occlusion developing during treatment with methimazole.

Takuji Yasude1, Dai Kishida, Ko-Ichi Tazawa, Masayuki Matsuda, Wataru Ishii, Masahide Yazaki, Shu-Ichi Ikeda.   

Abstract

A 63-year-old woman suddenly developed central retinal artery occlusion following a slight fever while being treated with methimazole (MMI) for hyperthyroidism. She was diagnosed to have anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) based on increased inflammatory reactions with positive myeloperoxidase-ANCA in the serum. Her visual acuity remained low despite immediate treatment with corticosteroids and cyclophosphamide after cessation of MMI, which may have played a role in the pathogenesis of AAV. Central retinal artery occlusion is a rare manifestation of AAV; however, it is important with regard to the possibility of serious sequelae.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23154728     DOI: 10.2169/internalmedicine.51.8486

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use.

Authors:  Deep Shikha; Jonathan Harris; Christine Resta; Patricia Park
Journal:  Case Rep Endocrinol       Date:  2015-04-28

Review 2.  Therapy of ocular complications in ANCA+ associated vasculitis.

Authors:  Simion Macarie Sorin; Mihăilă Răzvan-Marian; Mariana Macarie Daniela; Toc Dan-Alexandru
Journal:  Rom J Ophthalmol       Date:  2021 Jan-Mar

3.  Branch retinal artery occlusion in the untreated contralateral eye following aflibercept injections during heparin treatment: Possible contribution of a heparin-induced thrombocytopenia-like condition.

Authors:  Shintaro Nakao; Makoto Yoshimitsu; Yoshihiro Kaizu; Iori Wada; Muneo Yamaguchi; Koh-Hei Sonoda
Journal:  Am J Ophthalmol Case Rep       Date:  2019-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.